MedPath

Qilu Pharmaceutical (Inner Mongolia)-20%w/w Chlortetracycline Premix

Registration Number: MAL25016035HA

Approved
Approval ID

2546d06a3bf23f7c

Registration Number

MAL25016035HA

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types1 type
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (1)

25 kgAvailable
Package Size: 25 kg
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (1)

Chlortetracycline Calcium ComplexActive
Monograph: chlortetracycline calcium complex

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Qilu Pharmaceutical (Inner Mongolia)-20%w/w Chlortetracycline Premix - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform